Silo pharma adds japanese patent to expanding global ip portfolio for licensed ptsd drug

Sarasota, fl, sept. 09, 2025 (globe newswire) -- silo pharma, inc. (nasdaq: silo) (“silo” or “the company), a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company, today announced that the japan patent office has granted patent number 7683882 to silo's research and licensing partner columbia university for the invention titled “prophylactic efficacy of serotonin 4 receptor agonists against stress,” exclusively licensed to silo by columbia university. columbia university recently received an australian patent for the same invention.
SILO Ratings Summary
SILO Quant Ranking